Standard Chemical & Pharmaceutical Co., Ltd.

NT$55.30As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1720Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 11.06%
Div yield 3.29%
ROE 15.39%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.01
PE TTM 10.62
TSR TTM 13.17%
Mkt cap NT$9.882B
ROIC 15.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$68
23.62%
(90.85%)
Hold 11|9|9|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.47
0.50
0.51
0.54
(4.50%)
0.31%
5.23%
14.23%
RevenueNT$M
521.1
548.6
542.1
573.1
11.08%
16.27%
11.71%
14.05%
Peers (US$298.5M)
Cap (US$)
PE
444.5M
17.80x
360.2M
10.47x
294.9M
14.89x
Capital
TTM
5Y
10Y
Leveragex
1.931
14.52
14.00
EBIT/Intx
1.782
0.267
0.227
Own earn%
364.33
102.69
93.09
Sh yield%
38.71
14.65
14.56
Owners
Insiders/Inst%
11.99
28.15
Short interest%
3.46
SBC / revenue%
4.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
2–8
$1 testx
0.0
Incr. ROIC%
5